<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04589338</url>
  </required_header>
  <id_info>
    <org_study_id>20202021</org_study_id>
    <nct_id>NCT04589338</nct_id>
  </id_info>
  <brief_title>Impact of Different Types of Physical Activity in Patients With Chronic Inflammatory Bowel Disease</brief_title>
  <acronym>ACHILLE</acronym>
  <official_title>Impact of Different Types of Physical Activity in Patients With Chronic Inflammatory Bowel Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Liege</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Liege</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective interventional study. The investigators will include patients in&#xD;
      clinical remission who are on stable treatment. These IBD patients will be followed to&#xD;
      analyze the effects of physical activity on their inflammatory disease. Different exercises&#xD;
      will be offered to two separate groups of randomly distributed patients: the first group will&#xD;
      perform muscle building exercises while the other group will be offered aerobic&#xD;
      exercises.There will also be a control group that does not initially benefit from a specific&#xD;
      physical activity program. However, this group will be integrated into one of the other two&#xD;
      groups after the 10-week follow-up. All three groups will perform the same baseline tests.&#xD;
      These will be of different types: physical tests, biological tests and quality of life&#xD;
      questionnaires.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 5, 2021</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Progressive effort test on bicycle ergometer (VO2 max)</measure>
    <time_frame>day 1</time_frame>
    <description>This test allows to measure VO2 in ml/min/kg (thanks to respiratory gases)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Progressive effort test on bicycle ergometer (VO2 max)</measure>
    <time_frame>through study completion, an average of 40 weeks</time_frame>
    <description>This test allows to measure VO2 in ml/min/kg (thanks to respiratory gases)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Progressive effort test on bicycle ergometer (Heart rate)</measure>
    <time_frame>day 1</time_frame>
    <description>This test allows to measure resting and maximum heart rate (thanks to an ECG) and maximum aerobic power in Watt.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Progressive effort test on bicycle ergometer (Heart rate)</measure>
    <time_frame>through study completion, an average of 40 weeks</time_frame>
    <description>This test allows to measure resting and maximum heart rate (thanks to an ECG) and maximum aerobic power in Watt.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Progressive effort test on bicycle ergometer (Power)</measure>
    <time_frame>day 1</time_frame>
    <description>This test allows to measure maximum aerobic power in Watt.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Progressive effort test on bicycle ergometer (Power)</measure>
    <time_frame>through study completion, an average of 40 weeks</time_frame>
    <description>This test allows to measure maximum aerobic power in Watt.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximum force test (N/m)</measure>
    <time_frame>Day 1</time_frame>
    <description>This test will be performed using an isokinetic dynamometer. This evaluation will allow us to determine the maximum force of the quadriceps and hamstrings of each participant in N/m.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximum force test (N/m)</measure>
    <time_frame>through study completion, an average of 40 weeks</time_frame>
    <description>This test will be performed using an isokinetic dynamometer. This evaluation will allow us to determine the maximum force of the quadriceps and hamstrings of each participant in N/m.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood sample</measure>
    <time_frame>Day 1</time_frame>
    <description>This type of tests includes biological monitoring to obtain information on biological parameters.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood sample</measure>
    <time_frame>through study completion, an average of 40 weeks</time_frame>
    <description>This type of tests includes biological monitoring to obtain information on biological parameters.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Saddle analysis</measure>
    <time_frame>Day 1</time_frame>
    <description>This type of tests includes biological monitoring to obtain information on biological parameters.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Saddle analysis</measure>
    <time_frame>through study completion, an average of 40 weeks</time_frame>
    <description>This type of tests includes biological monitoring to obtain information on biological parameters.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IBD-F</measure>
    <time_frame>Week 1</time_frame>
    <description>Participants will complete a questionnaire on fatigue perceived.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IBD-F</measure>
    <time_frame>Week 10</time_frame>
    <description>Participants will complete a questionnaire on fatigue perceived.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IBD-F</measure>
    <time_frame>Week 20</time_frame>
    <description>Participants will complete a questionnaire on fatigue perceived.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Godin Leisure Time exercise questionnaire</measure>
    <time_frame>Week 1</time_frame>
    <description>Participants will complete a questionnaire on the level of physical activity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Metabolic Equivalent Task questionnaire</measure>
    <time_frame>Week 1</time_frame>
    <description>Participants will complete a questionnaire on the level of inactivity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Metabolic Equivalent Task questionnaire</measure>
    <time_frame>Week 10</time_frame>
    <description>Participants will complete a questionnaire on the level of inactivity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Metabolic Equivalent Task questionnaire</measure>
    <time_frame>Week 20</time_frame>
    <description>Participants will complete a questionnaire on the level of inactivity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Short Food Frequency Questionnaire</measure>
    <time_frame>Week 1</time_frame>
    <description>Participants will complete a questionnaire on their dietary habits</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Short Food Frequency Questionnaire</measure>
    <time_frame>Week 10</time_frame>
    <description>Participants will complete a questionnaire on their dietary habits</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Short Food Frequency Questionnaire</measure>
    <time_frame>Week 20</time_frame>
    <description>Participants will complete a questionnaire on their dietary habits</description>
  </primary_outcome>
  <primary_outcome>
    <measure>EQ5D questionnaire</measure>
    <time_frame>Week 1</time_frame>
    <description>Participants will complete a questionnaire on their level of health</description>
  </primary_outcome>
  <primary_outcome>
    <measure>EQ5D questionnaire</measure>
    <time_frame>Week 10</time_frame>
    <description>Participants will complete a questionnaire on their level of health</description>
  </primary_outcome>
  <primary_outcome>
    <measure>EQ5D questionnaire</measure>
    <time_frame>Week 20</time_frame>
    <description>Participants will complete a questionnaire on their level of health</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Short health scale questionnaire</measure>
    <time_frame>Week 1</time_frame>
    <description>Participants will complete a questionnaire to evaluate the level of the inflammatory bowel disease</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Short health scale questionnaire</measure>
    <time_frame>Week 10</time_frame>
    <description>Participants will complete a questionnaire to evaluate the level of the inflammatory bowel disease</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Short health scale questionnaire</measure>
    <time_frame>Week 20</time_frame>
    <description>Participants will complete a questionnaire to evaluate the level of the inflammatory bowel disease</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Inflammatory Bowel Diseases</condition>
  <condition>Exercise Therapy</condition>
  <arm_group>
    <arm_group_label>Endurance training group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Resistance training group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Endurance training</intervention_name>
    <description>This group will perform aerobic type exercises. Initially, patients will perform continuous exercises of progressive intensity in order to adapt to this kind of effort. Next, we will introduce interval exercises.</description>
    <arm_group_label>Endurance training group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resistance training</intervention_name>
    <description>Patients in this group will perform lower limb strengthening exercises to improve the maximum strength of different muscle groups.</description>
    <arm_group_label>Resistance training group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients in remission defined by a Harvey Bradshaw Index 5 in Crohn's disease (CD) and&#xD;
             a clinical Mayo 3 with no sub-score &gt;1 in ulcerative colitis (RCUH) with stable&#xD;
             treatment, without corticosteroid for 4 months.&#xD;
&#xD;
          -  Patients accepting the study protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients suffering from other pathologies (at the level of the digestive system, the&#xD;
             cardiovascular system, as well as the musculoskeletal system: recent knee plasty,&#xD;
             recent knee fractures, etc.), which can interfere with planned tests and activity&#xD;
             programs.&#xD;
&#xD;
          -  Patients with more than 3 hours of sports activity per week&#xD;
&#xD;
          -  Pregnant, pregnant or nursing patients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Amandine Gofflot</last_name>
    <phone>+3243662193</phone>
    <email>agofflot@uliege.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Université de Liège</name>
      <address>
        <city>Liège</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amandine Gofflot</last_name>
      <phone>+3243662193</phone>
      <email>agofflot@uliege.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>September 22, 2020</study_first_submitted>
  <study_first_submitted_qc>October 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2020</study_first_posted>
  <last_update_submitted>April 26, 2021</last_update_submitted>
  <last_update_submitted_qc>April 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Liege</investigator_affiliation>
    <investigator_full_name>Gofflot Amandine</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

